Inochi Care is an Indian medical-device company, born out of AIIMS and IIT Delhi, building Negative Pressure Wound Therapy (NPWT) and Topical Oxygen Therapy systems for diabetic foot ulcers, pressure injuries and chronic, infected wounds.
CDSCO approved device
NPWT + TOT in one cycle
Two NPWT systems already in clinical use, the consumables that go with them — and more on the way.
The first portable system that automatically alternates Negative Pressure Wound Therapy and Topical Oxygen Therapy in a single, uninterrupted cycle — for hospital wound-care units.
A lightweight, battery-powered Negative Pressure Wound Therapy system that keeps therapy running without tying the patient to a bedside unit.
Sterile dressing kits and accessories designed for InoHeal and InoHeal Pro therapy.
A new product is about to launch, with another following later this year. Be the first to know.
Three barriers feed each other and keep a wound stuck. Standard NPWT clears exudate — but it cannot fix the oxygen deficit.
Shields bacteria from antibiotics and topical treatments.
Washes away growth factors and breaks down new tissue.
Below 20 mmHg of oxygen, repair and infection defence stall.
InoHeal Pro automatically sequences NPWT and Topical Oxygen Therapy in a continuous cycle — combination therapy with no clinician intervention between phases.
Regulated negative pressure (−40 to −200 mmHg, 5 mmHg steps) removes exudate and the conditions that favour biofilm. PID control holds ±5% accuracy at the wound — NABL certified.
100% medical-grade oxygen at 10 mBar lifts wound-surface pO₂ to 767–770 mmHg — about 5× atmospheric — directly correcting the hypoxia that blocks closure.
A pre-configured programme switches between therapies without dressing changes. No manual switching. No therapy gaps.
Pooled results for combined NPWT + Topical Oxygen Therapy versus standard NPWT alone.
Significantly faster wound closure vs standard NPWT alone.
Substantially reduced wound infection and related complications.
Patients healed nearly 10 days sooner on average.
Complex neuropathic wounds with compromised healing.
Stage III–IV pressure injuries needing aggressive bed preparation and infection control.
Chronic venous wounds with high exudate burden and recurrence.
Dehisced or high-risk incisions needing faster granulation and closure.
High-energy soft-tissue injuries, degloving and complex lacerations.
Biofilm-burdened wounds refractory to standard protocols.
Evidence summaries, clinical protocols and dosing guidance for surgeons and wound-care nurses.
Device specifications, compliance documents, total-cost-of-care analysis and procurement.
Territory availability, regulatory dossier support and our partnership model.
Plain-language guides to the therapy, what to expect and how to find a treating clinician.
Evaluating InoHeal for your unit, exploring distribution, or reviewing the evidence? Our clinical specialists are here to help.
Mon–Fri, 9:30 AM – 6:30 PM IST
We reply within one business day
New Delhi – 110020, India
Tell us a little about you and we will route your request to the right specialist.
